The programmed cell death 1 gene 7209 C>T polymorphism is associated with the risk of systemic lupus erythemathosus in the Polish population

Clinical and Experimental Rheumatology

Volumn 26, Issue 3, 2008, Pages 457-460

  Mostowska, Magdalena ^a   Wudarski, Mariusz ^b   Chwalińska Sadowska, Hanna ^b   Jagodziński, Paweł P ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b INSTITUTE OF RHEUMATOLOGY   (Poland)

Author keywords

PDCDI; Polymorphism; Systemic lupus erythematosus

Indexed keywords

ADENINE; CYTOSINE; GUANINE; MEMBRANE PROTEIN; PROGRAMMED CELL DEATH 1 PROTEIN; THYMINE;

ADULT; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; GENOTYPE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; NUCLEIC ACID BASE SUBSTITUTION; NUCLEOTIDE SEQUENCE; POLAND; POPULATION RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ANTIGENS, CD; APOPTOSIS REGULATORY PROTEINS; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; POLAND; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 48949117002     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. SEKIGAWA I, NAITO T, HIRA K et al.: Possible mechanisms of gender bias in SLE: a new hypothesis involving a comparison of SLE with atopy. Lupus 2004; 13: 217-22.
2. LOVE LA: New environmental agents associated with lupus-like disorders. Lupus 3: 1994; 467-71.
3. NORRIS DA: Pathomechanisms of photosensitive lupus erythematosus. J Invest Dermatol 1993; 100: 58-68.
4. PIOTROWSKI PC, DURIAGIN S, JAGODZINSKI PP: Expression of human endogenous retrovirus clone 4-1 may correlate with blood plasma concentration of anti-U1 RNP and anti-Sm nuclear antibodies. Clin Rheumatol 2005; 24: 620-4.
5. KALDEN JR: Defective phagocytosis of apoptotic cells: possible explanation for the induction of autoantibodies in SLE. Lupus 1997; 6: 326-7.
6. JANUCHOWSKI R, WUDARSKI M, CHWALINSKA-SADOWSKA H, JAGODZINSKI PP: Prevalence of ZAP-70, LAT, SLP-76, and DNA methyltransferase 1 expression in CD4(+) T cells of patients with systemic lupus erythematosus. Clin Rheumatol 2007; 10.1007/s10067-007-0644-8
7. KOTZIN BL: Systemic lupus erythematosus. Cell 1996; 85: 303-6.
8. NISHIMURA H, NOSE M, HIAI H, MINATO N, HONJO T: Development of lupus-like autoimmune diseases by disruption of the PDCD1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 1999; 11: 141-51.
9. WONG M, TSAO BP: Current topics in human SLE genetics. Springer Semin Immunopathol 2006; 28: 97-107.
10. HARLEY JB, KELLY JA, KAUFMAN KM: Unraveling the genetics of systemic lupus erythematosus. Springer Semin Immunopathol 2006; 28: 119-30.
11. IMANISHI T, MORINOBU A, HAYASHI N et al.: A novel polymorphism of the SSA1 gene is associated with anti-SS-A/Ro52 autoantibody in Japanese patients with primary Sjögren's syndrome. Clin Exp Rheumatol 2005; 23: 521-4.
12. AL-AWADHI AM, HAIDER MZ, SHARMA PN et al.: Angiotensin-converting enzyme gene polymorphism in Kuwaiti patients with systemic lupus erythematosus. Clin Exp Rheumatol 2007; 25: 437-42.
13. BURZYNSKI M, DURIAGIN S, MOSTOWSKA M, WUDARSKI M, CHWALINSKA-SADOWSKA H, JAGODZINSKI PP: MTR 2756 A > G polymorphism is associated with the risk of systemic lupus erythematosus in the Polish population. Lupus 2007; 16: 450-4.
14. WANG J, YOSHIDA T, NAKAKI F, HIAI H, OKAZAKI T, HONJO T: Establishment of NOD-Pdcd1-/- mice as an efficient animal model of type I diabetes. Proc Natl Acad Sci U S A. 2005; 102: 11823-28.
15. ANSARI MJ, SALAMA AD, CHITNIS T et al.: The programmed death-1 (PDCD1) pathway regulates autoimmune diabetes in non-obese diabetic (NOD) mice. J Exp Med 2003; 198: 63-9.
16. NISHIMURA H, OKAZAKI T, TANAKA Y et al.: Autoimmune dilated cardiomyopathy in PDCD1 receptor-deficient mice. Science 2001; 291: 319-22.
17. OKAZAKI T, TANAKA Y, NISHIO R et al.: Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PDCD1-deficient mice. Nat Med 2003; 9: 1477-83.
18. ISHIDA Y, AGATA Y, SHIBAHARA K: Induced expression of PDCD1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J 1992; 3887-95.
19. FREEMAN GJ, LONG AJ, IWAI Y et al.: Engagement of the PDCD1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med 2000; 192: 1027-34.
20. OKAZAKI T, MAEDA A, NISHIMURA H, KUROSAKI T, HONJO T: PDCD1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine. Proc Natl Acad Sci USA 2001; 98: 13866-71.
21. LATCHMAN Y, WOOD CR, CHERNOVA T et al.: PD-L2 is a second ligand for PDCD1 and inhibits T cell activation. Nat Immunol 2001; 2: 261-68.
22. MAGNUSSON V, LINDQVIST AK, CASTILLEJO-LOPEZ C et al.: Fine mapping of the SLEB2 locus involved in susceptibility to systemic lupus erythematosus. Genomics 2000; 70: 307-14.
23. LINDQVIST AK, STEINSSON K, JOHANNESON B et al.: A susceptibility locus for human systemic lupus erythematosus (hSLE1) on chromosome 2q. J Autoimmun 2000; 14: 169-78.
24. FERREIROS-VIDAL I, GOMEZ-REINO JJ, BARROS F et al.: Association of PDCD1 with susceptibility to systemic lupus erythematosus: evidence of population-specific effects. Arthritis Rheum 2004; 50: 2590-7.
25. JOHANSSON M, ARLESTIG L, MOLLER B, SMEDBY T, RANTAPAA-DAHLQVIST S: Association of a PDCD1 polymorphism with renal manifestations in systemic lupus erythematosus. Arthritis Rheum 2005; 52: 1665-9.
26. PROKUNINA L, PADYUKOV L, BENNET A et al.: Association of the PDCD1.3A allele of the PDCD1 gene in patients with rheumatoid arthritis negative for rheumatoid factor and the shared epitope. Arthritis Rheum 2004; 50: 1770-3.
27. KONG EK, PROKUNINA-OLSSON L, WONG WH et al.: A new haplotype of PDCD1 is associated with rheumatoid arthritis in Hong Kong Chinese. Arthritis Rheum 2005; 52: 1058-62.
28. LIN SC, YEN JH, TSAI JJ et al.: Association of a programmed death 1 gene polymorphism with the development of rheumatoid arthritis, but not systemic lupus erythematosus. Arthritis Rheum 2004; 50: 770-5.
29. NIELSEN C, HANSEN D, HUSBY S et al.: Association of a putative regulatory polymorphism in the PDCD1 gene with susceptibility to type 1 diabetes. Tissue Antigens 2003; 62: 492-7.
30. KRONER A, MEHLING M, HEMMER B et al.: A PDCD1 polymorphism is associated with disease progression in multiple sclerosis. Ann Neurol 2005; 58: 50-7.
31. PROKUNINA L, CASTILLEJO-LOPEZ C, OBERG F et al.: A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nat Genet 2002; 32: 666-9.
32. WANG SC, CHEN YJ, OU TT et al.: Programmed death-1 gene polymorphisms in patients with systemic lupus erythematosus in Taiwan. J Clin Immunol 2006; 26: 506-11.
33. TAN EM, COHEN AS, FRIES JF et al.: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7.
34. HOCHBERG MC: Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.
35. THORBURN CM, PROKUNINA-OLSSON L, STERBA KA et al.: Association of PDCD1 genetic variation with risk and clinical manifestations of systemic lupus erythematosus in a multiethnic cohort. Genes Immun 2007; doi: 10.1038/sj.gene.6364383
36. FERREIROS-VIDAL I, D'ALFONSO S, PAPASTERIADES C et al.: Bias in association studies of systemic lupus erythematosus susceptibility due to geographical variation in the frequency of a programmed cell death 1 polymorphism across Europe. Genes Immun 8: 138-46.
37. PROKUNINA L, GUNNARSSON I, STURFELT G et al.: The systemic lupus erythematosus-associated PDCD1 polymorphism PD1.3A in lupus nephritis Arthritis Rheum 2004; 50: 327-28.